Commonly Used Medicines On Neonatal Units in the UK

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

642729 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-20

Study Completion Date

2021-04-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective analysis of drug utilisation data aims to study the patterns of use of medicines in neonatal units in the UK from 2010 to 2017. Prescribing drugs in neonates can be complex and the application of pharmacotherapy principles can be challenging due to the lack of licenced formulations and limited evidence-base for indications, dosing and/or adverse events. A systematic review of drug utilisation pattern in neonatal units in different health care settings identified antibiotics, caffeine and vitamin supplements as the most commonly used drugs and highlighted that further research is needed to investigate drug utilisation and rational use of medicines in neonates. The only UK study included in this systematic review and available from our search of literature was conducted in 2009. This survey, however, had a low response rate (only 42% units responded) and it included data collection over a very short period of 2 weeks and that could limit its generalisability to other NICU settings. It identified the need for research in to medicines for neonates and that this research agenda should be informed by the extent of medication use in this field. However, our literature search revealed that there is very little information on the current patterns of medication use in neonates. An updated drug utilisation study is warranted in a neonatal setting in UK.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Inadvertent Hyperventilation During Intraoperative Care in Neonates

NCT03823716

Neonatal Disorder

COMPLETED

Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life.

NCT00715000

Low Birth Weight Infant Enteral Nutrition

COMPLETED PHASE4

Integrated Prediction of Extubation Outcome by the Spontaneous Breathing Trial in Newborn Infants

NCT03956511

Infant, Newborn, Diseases Airway Morbidity

COMPLETED

Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy

NCT03129620

Hypothermia

COMPLETED

Which Infants in a Neonatal Unit Are at Most Risk of Feeding Difficulties?

NCT02867410

Infants Admitted to Neonatal Units

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to investigate current and recent patterns of drug utilisation in neonatal units in the UK.

We will conduct a retrospective pharmacoepidemiological study of a large prospectively collected database (The National Neonatal Research Database -REC Number 16/LO/1093). The study will use de-identified historical data recorded in this database. There is no patient recruitment and the project involves no changes to patient care. The data to be used for this project are stored in de-identified form.

Data items will include descriptive, background data to allow for age and gestation at the time of drug use and subgroup analysis (such as birth weight, gestational age, clinical condition, day of drug use) and data on drug use (name of drug and age at use).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant, Newborn Pharmacoepidemiology Intensive Care Units, Neonatal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This is a retrospective, observational pharmacoepidemiological study using nationally collected data. There is no intervention.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants admitted to neonatal units in England, Scotland, and Wales
* Admitted between 01 January 2010 and 31 December 2017.
* No limits in gestational age or birth weight.

Exclusion cirteria

* Infants who received all their care in the postnatal ward
* Infants who were not admitted to any neonatal unit

Minimum Eligible Age

0 Weeks

Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No